← Evidence map

ArticleOncogene2015

Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.

H Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

32 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25823021